We are live on ! Find out more

4 hedge funds and large institutions have $8.03M invested in iHuman in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.04% less ownership

Funds ownership: 5% → 4.96% (-0.04%)

50% less funds holding

Funds holding: 8 → 4 (-4)

87% less capital inflows, than outflows

Capital inflows: $11.8K | Capital outflows: $89.2K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
4
Holders Change
-4
Holders Change %
-50%
% of All Funds
0.06%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
–
Increased
2
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IH Hedge Fund Activity: Q4 2023 in Review

4 of the 6,880 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q4 2023, worth a combined $8.03M — up 0.69% from $7.97M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of IH and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was RhumbLine Advisers, adding an estimated $6.66K. The largest seller was Citadel Advisors, exiting entirely with an estimated $43.8K sold.

  • 4 institutional investors held iHuman (IH) as of Q4 2023, down from 8 in Q3 2023.
  • Funds reported $8.03M of iHuman stock for Q4 2023, up 0.69% quarter-over-quarter.
  • 0 funds opened new iHuman positions in Q4 2023 and 4 closed out, a net change of -4 holders.
  • The largest iHuman buyer in Q4 2023 was RhumbLine Advisers, an estimated $6.66K added.
  • The largest iHuman seller in Q4 2023 was Citadel Advisors, an estimated $43.8K sold.

Based on aggregated 13F filings for Q4 2023.